+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Bioidentical Hormones Market (2021-2026) by Type, Product Type, End-User, Distribution Channel, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • PDF Icon

    Report

  • 182 Pages
  • May 2021
  • Region: Global
  • Infogence Global Research
  • ID: 5397302
The Global Bioidentical Hormones Market is estimated to be USD 340.6 Mn in 2021 and is expected to reach USD 826.54 Mn by 2026, growing at a CAGR of 19.40%.



Market Dynamics

The increasing government initiatives towards the health sector, the rising level of screening of hormonal deficiency, and growing healthcare expenditure have prompted the demand of the bioidentical hormones market. In addition, the increasing geriatric population, rising awareness, and focus on female healthcare have escalated the market growth. According to a study conducted by researchers from the Obstetrics and Gynaecology Department of Kafkas University in January 2019, nearly 432 females out of 926 opted for bio-identical hormone replacement therapy to treat their menopausal symptoms in Turkey. However, side effects associated with bioidentical hormone treatment, such as weight loss, breast cancer, heart attacks, etc., hinder the market growth.

Innovations in bioidentical hormones by the key players are expected to create variety of opportunities for the market participants.

Market Segmentation

The Global Bioidentical Hormones Market is segmented further based on Type, Product Type, End-User, Distribution Channel, and Geography.

By Type, the market is classified into Estrogen, Progesterone, Testosterone, Combined Hormones, and others. Amongst all, the Estrogen segment is estimated to hold the highest market share during the forecast period.

By Product Type, the market is classified as tablets and capsules, creams and gels, injectables, patches and implants, and others. Amongst all, the tablets and capsules segment is estimated to hold the highest market share during the forecast period.

By End User, the market is classified as Hospital, Gynecology Clinics, Academics And Research, and Others. Amongst all, the Hospital segment is estimated to hold the highest market share during the forecast period.

By Distribution Channel, the market is classified as Hospital Pharmacies, Retail Pharmacies, Online Pharmacies. Amongst all, the Retail Pharmacies segment is estimated to hold the highest market share during the forecast period.

By Geography, North America is projected to lead the market.

Recent Developments

1. TherapeuticsMD and Theramex announced the approval of BIJUVE capsules indicated for hormone replacement therapy in the United Kingdom, under the trade name BIJUVA - 8th April 2021
2. Foresee Pharmaceuticals receives FDA approval of CAMCEVI, gonadotropin-releasing hormone (GnRH) agonist for the treatment of advanced prostate cancer - 26th May 2021

Company Profiles

Some of the companies covered in this report are Bayers AG, Biostation, BioTE Medical, Bravado Labs, Defy Medical LLC, etc.

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Bioidentical Hormones Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst’s positioning tool.

Report Highlights:
  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Bioidentical Hormones Market

What is the estimated value of the Global Bioidentical Hormones Market?

The Global Bioidentical Hormones Market was estimated to be valued at $340.6 Million in 2021.

What is the growth rate of the Global Bioidentical Hormones Market?

The growth rate of the Global Bioidentical Hormones Market is 19.4%, with an estimated value of $826.54 Million by 2026.

What is the forecasted size of the Global Bioidentical Hormones Market?

The Global Bioidentical Hormones Market is estimated to be worth $826.54 Million by 2026.

Who are the key companies in the Global Bioidentical Hormones Market?

Key companies in the Global Bioidentical Hormones Market include Allergan Inc, Abbott Laboratories, Actiza Pharmaceutical Private Limited, Bayers AG, The Biostation, BioTE Medical, Bravado Labs, Defy Medical LLC and InMode Ltd.

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Shareholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size and Segmentation
3.3 Market Outlook
4 Market Influencers
4.1 Drivers
4.1.1 Increase Awareness about Hormone Deficiency
4.1.2 Rising Prevalence of Hormonal Imbalance Disorders
4.1.3 Rise In Healthcare Expenditures
4.2 Restraints
4.2.1 Stringent Regulation and Complicated Approval Procedure
4.2.2 Side Effects Associated with the Treatment
4.3 Opportunities
4.3.1 Government Initiative and Support
4.3.2 Rising Focus on Women Healthcare
4.4 Challenges
4.4.1 Lack of Quality Control for Customized Compounded Bioidentical Hormones
4.5 Trends
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter’s Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Bioidentical Hormones Market, By Type
6.1 Introduction
6.2 Estrogen
6.3 Progesterone
6.4 Testosterone
6.5 Combined Hormones
6.6 Others
7 Global Bioidentical Hormones Market, By Product
7.1 Introduction
7.2 Creams & Gels
7.3 Injectable
7.4 Patches & Implants
7.5 Tablet & Capsules
7.6 Others
8 Global Bioidentical Hormones Market, By End Users
8.1 Introduction
8.2 Gynecology Clinics
8.3 Academics and Research Institutes
8.4 Hospitals and Clinics
8.5 Others
9 Global Bioidentical Hormones Market, By Distribution Channel
9.1 Introduction
9.2 Hospital Pharmacies
9.3 Retail Pharmacies
9.4 Online Pharmacies
10 Global Bioidentical Hormones Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 South America
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Chile
10.3.4 Colombia
10.4 Europe
10.4.1 UK
10.4.2 France
10.4.3 Germany
10.4.4 Italy
10.4.5 Spain
10.4.6 Netherlands
10.4.7 Sweden
10.4.8 Russia
10.4.9 Rest of Europe
10.5 Asia-Pacific
10.5.1 China
10.5.2 Japan
10.5.3 India
10.5.4 Indonesia
10.5.5 Malaysia
10.5.6 South Korea
10.5.7 Australia
10.5.8 Sri Lanka
10.5.9 Thailand
10.5.10 Rest of APAC
10.6 Middle-East and Africa
10.6.1 Qatar
10.6.2 Saudi Arabia
10.6.3 South Africa
10.6.4 United Arab Emirates
11 Competitive Landscape
11.1 Competitive Quadrant
11.2 Market Share Analysis
11.3 Strategic Initiatives
11.3.1 M&A and Investments
11.3.2 Partnerships and Collaborations
11.3.3 Product Developments and Improvements
12 Company Profiles
12.1 Allergan Inc
12.2 Abbott Laboratories
12.3 Actiza Pharmaceutical Private Limited
12.4 Bayers AG
12.5 The Biostation
12.6 BioTE Medical
12.7 Bravado Labs
12.8 Defy Medical LLC
12.9 GeneScience Pharmaceuticals Co. Ltd
12.10 InMode Ltd
12.11 Merck Group
12.12 NextGenRx Compounding Pharmacy
12.13 Novartis AG
12.14 Noven Pharmaceuticals, Inc.
12.15 Novo Nordisk A/S
12.16 Nueva Aesthetic
12.17 Papillon Medical
12.18 Pellecome LLC
12.19 Orion Pharma AB
12.20 Pavilion Compounding Pharmacy, LLC
12.21 Pellecome LLC
12.22 Pfizer Inc
12.23 Schwietermans Pharmacy
12.24 SottoPelle
12.25 Suprema HQ
12.26 TherapeuticsMD Inc
12.27 ZRT Laboratory
12.28 United Pharmacy, LLC
13 Appendix
13.1 Questionnaire

Companies Mentioned

  • Allergan Inc
  • Abbott Laboratories
  • Actiza Pharmaceutical Private Limited
  • Bayers AG
  • The Biostation
  • BioTE Medical
  • Bravado Labs
  • Defy Medical LLC
  • GeneScience Pharmaceuticals Co. Ltd
  • InMode Ltd
  • Merck Group
  • NextGenRx Compounding Pharmacy
  • Novartis AG
  • Noven Pharmaceuticals, Inc.
  • Novo Nordisk A/S
  • Nueva Aesthetic
  • Papillon Medical
  • Pellecome LLC
  • Orion Pharma AB
  • Pavilion Compounding Pharmacy, LLC
  • Pellecome LLC
  • Pfizer Inc
  • Schwietermans Pharmacy
  • SottoPelle
  • Suprema HQ
  • TherapeuticsMD Inc
  • ZRT Laboratory
  • United Pharmacy, LLC